CoChat

Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations

Open access
Shin, Dongju, Lee, Wookjae, Lee, Ji Hyun, Bang, Duhee · 2019 · Science Advances

Published version of a preprint

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

The authors developed a method for analyzing single cells under various conditions by tagging cells with small fragments of DNA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.aav2249

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Scheme and validation of transient barcoding method. (A) Scheme of multiplexed scRNA-seq by transient barcoding method using SBOs. (1) Samples with various conditions are prepared. (2) Each sample is transfected with SBO containing a unique sample barcode. (3) Barcoded cells are pooled together and processed for scRNA-seq (e.g., Drop-Seq). (4) Cells are lysed within droplets, and the released mRNAs and SBOs are captured, reverse-transcribed, and sequenced. (5) Cells are demultiplexed and assigned to their origins and processed for further analysis. (B) Heatmap of normalized SBO counts for 6-plex human/mouse species-mixing experiment. Rows represent cells, and columns represent SBOs. Cells are assessed whether they are positive for a particular SBO based on the SBO count matrix (see Materials and Methods). Cells were classified as singlets (positive for a unique SBO), multiplets (positive for more than one SBO), or negatives (not positive for any SBO) and ordered by their classifications. (C) Scatter plot showing raw counts between two SBOs. SBOs 1 and 6 were used to barcode different samples (Human 1, Mouse 2) (left). SBOs 3 and 4 were used to barcode the same sample (Human 3) (right). (D) Species-mixing plot of samples associated with SBOs 1 and 5. Cells were labeled according to their SBO classifications. Black dots indicate Human 1 sample barcoded with SBO 1, red dots indicate Mouse 1 sample barcoded with SBO 5, and gray dots indicate doublets that are positive for both SBOs. (E) Distribution of RNA transcript counts in cells between singlets (green), multiplets (blue), and negatives (red). Negatives, which imply beads exposed to ambient RNA, had the lowest number of transcripts. Multiplets had slightly more transcripts than singlets, indicating more RNA content within a droplet.
Fig. 1 Scheme and validation of transient barcoding method. (A) Scheme of multiplexed scRNA-seq by transient barcoding method using SBOs. (1) Samples with various conditions are prepared. (2) Each sample is transfected with SBO containing a unique sample barcode. (3) Barcoded cells are pooled together and processed for scRNA-seq (e.g., Drop-Seq). (4) Cells are lysed within droplets, and the released mRNAs and SBOs are captured, reverse-transcribed, and sequenced. (5) Cells are demultiplexed and assigned to their origins and processed for further analysis. (B) Heatmap of normalized SBO counts for 6-plex human/mouse species-mixing experiment. Rows represent cells, and columns represent SBOs. Cells are assessed whether they are positive for a particular SBO based on the SBO count matrix (see Materials and Methods). Cells were classified as singlets (positive for a unique SBO), multiplets (positive for more than one SBO), or negatives (not positive for any SBO) and ordered by their classifications. (C) Scatter plot showing raw counts between two SBOs. SBOs 1 and 6 were used to barcode different samples (Human 1, Mouse 2) (left). SBOs 3 and 4 were used to barcode the same sample (Human 3) (right). (D) Species-mixing plot of samples associated with SBOs 1 and 5. Cells were labeled according to their SBO classifications. Black dots indicate Human 1 sample barcoded with SBO 1, red dots indicate Mouse 1 sample barcoded with SBO 5, and gray dots indicate doublets that are positive for both SBOs. (E) Distribution of RNA transcript counts in cells between singlets (green), multiplets (blue), and negatives (red). Negatives, which imply beads exposed to ambient RNA, had the lowest number of transcripts. Multiplets had slightly more transcripts than singlets, indicating more RNA content within a droplet.CC BY-NC · PubMed Central
Fig. 2 Pseudotime analysis in 5-plex time-course experiment. (A) Monocle pseudotime trajectory of K562 cells treated with imatinib at different time points. Cells are labeled by pseudotime (top) and drug treatment time (bottom). The 0-, 6-, 12-, 24-, and 48-hour samples consist of 133, 109, 79, 49, 58, 52, and 90 cells, respectively. (B) Boxplot showing the distribution of pseudotime within each sample. (C) Prominent gene expression alterations in 5-plex time-course experiments of imatinib treatment. Note that the cells are labeled by drug treatment time and are not synchronously distributed over pseudotime. (D) Expression heatmap showing 50 genes with the lowest q values. (E) Expression heatmap showing DEGs between two transition states with q < 1 ×10−4. Prebranch refers to the cells before branch 1, Cell fate 1 refers to the cells of upper transition state, and Cell fate 2 refers to the cells in the lower transition state.
Fig. 2 Pseudotime analysis in 5-plex time-course experiment. (A) Monocle pseudotime trajectory of K562 cells treated with imatinib at different time points. Cells are labeled by pseudotime (top) and drug treatment time (bottom). The 0-, 6-, 12-, 24-, and 48-hour samples consist of 133, 109, 79, 49, 58, 52, and 90 cells, respectively. (B) Boxplot showing the distribution of pseudotime within each sample. (C) Prominent gene expression alterations in 5-plex time-course experiments of imatinib treatment. Note that the cells are labeled by drug treatment time and are not synchronously distributed over pseudotime. (D) Expression heatmap showing 50 genes with the lowest q values. (E) Expression heatmap showing DEGs between two transition states with q < 1 ×10−4. Prebranch refers to the cells before branch 1, Cell fate 1 refers to the cells of upper transition state, and Cell fate 2 refers to the cells in the lower transition state.CC BY-NC · PubMed Central
Fig. 3 Gene expression analysis in 48-plex drug treatment experiments. (A) Hierarchical clustered heatmap of averaged gene expression profiles for 48-plex drug treatment experiments in K562 cells. Each column represents averaged data in a drug, and each row represents a gene. DEGs were used in this heatmap. The scale bar of relative expression is on the right side. The ability of the drugs to inhibit kinase proteins is shown as binary colors (dark gray indicating positive) at the top. The bar plot at the top shows the cell count for each. (B) Volcano plot displaying DEGs of imatinib mesylate compared with DMSO controls. Genes that have a P value smaller than 0.05 and an absolute value of log (fold change) larger than 0.25 are considered significant. Up-regulated genes are colored in green, down-regulated genes are colored in red, and insignificant genes are colored in gray. Ten genes with the lowest P value are labeled. (C) Venn diagram showing the relationship between DEGs of three drug groups. Fourteen drugs are classified into three groups according to their protein targets (see Fig. 2C, top), and differential expression analysis is performed by comparing each group with DMSO controls. Relations of both positively (left) and negatively (right) regulated genes in each group are shown. (D) Plot showing a correlation between fold changes of expression in cells treated with mTOR inhibitors and BCR-ABL inhibitors compared with DMSO controls.
Fig. 3 Gene expression analysis in 48-plex drug treatment experiments. (A) Hierarchical clustered heatmap of averaged gene expression profiles for 48-plex drug treatment experiments in K562 cells. Each column represents averaged data in a drug, and each row represents a gene. DEGs were used in this heatmap. The scale bar of relative expression is on the right side. The ability of the drugs to inhibit kinase proteins is shown as binary colors (dark gray indicating positive) at the top. The bar plot at the top shows the cell count for each. (B) Volcano plot displaying DEGs of imatinib mesylate compared with DMSO controls. Genes that have a P value smaller than 0.05 and an absolute value of log (fold change) larger than 0.25 are considered significant. Up-regulated genes are colored in green, down-regulated genes are colored in red, and insignificant genes are colored in gray. Ten genes with the lowest P value are labeled. (C) Venn diagram showing the relationship between DEGs of three drug groups. Fourteen drugs are classified into three groups according to their protein targets (see Fig. 2C, top), and differential expression analysis is performed by comparing each group with DMSO controls. Relations of both positively (left) and negatively (right) regulated genes in each group are shown. (D) Plot showing a correlation between fold changes of expression in cells treated with mTOR inhibitors and BCR-ABL inhibitors compared with DMSO controls.CC BY-NC · PubMed Central
Fig. 4 Single-cell analysis in 48-plex drug treatment experiments. (A) The t-distributed stochastic neighbor embedding (t-SNE) plot of single cells in the 48-plex K562 samples. Plot shows six clusters (top), and additional t-SNE plot is labeled by cell cycle states (bottom). (B) Bar plots for 48-plex drug treatment experiments in K562 cells. The ability of the drugs to inhibit kinase proteins is shown as binary colors at the top (from Fig. 3A). The bar plot in the middle represents a relative fraction of cells in each t-SNE cluster [shown in (A)], and the bottom bar plot displays fractions of cell cycle states for every sample. Drugs are sorted by hierarchical clustering. (C) Expression heatmap showing the markers of the clusters. The numbers at the bottom represent cluster numbers. (D) Scaled expression of representative genes within the t-SNE plot. Intensity of the purple color determines expression levels, with higher intensity correlating with higher gene expression.
Fig. 4 Single-cell analysis in 48-plex drug treatment experiments. (A) The t-distributed stochastic neighbor embedding (t-SNE) plot of single cells in the 48-plex K562 samples. Plot shows six clusters (top), and additional t-SNE plot is labeled by cell cycle states (bottom). (B) Bar plots for 48-plex drug treatment experiments in K562 cells. The ability of the drugs to inhibit kinase proteins is shown as binary colors at the top (from Fig. 3A). The bar plot in the middle represents a relative fraction of cells in each t-SNE cluster [shown in (A)], and the bottom bar plot displays fractions of cell cycle states for every sample. Drugs are sorted by hierarchical clustering. (C) Expression heatmap showing the markers of the clusters. The numbers at the bottom represent cluster numbers. (D) Scaled expression of representative genes within the t-SNE plot. Intensity of the purple color determines expression levels, with higher intensity correlating with higher gene expression.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. Q. Mao, L. Wang, S. Goodison, Y. Sun, paper presented at the Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Sydney, NSW, Australia, 10 to 13 August 2015.

Cited by

See all 102

Metadata

Authors
Shin, D., Lee, W., Lee, J. H., & Bang, D.
Affiliations
  • Yonsei University (KR)
  • Kyung Hee University (KR)
Venue
Science Advances
Published
2019-05-03
Volume
5
Issue
5
Pages
eaav2249-eaav2249
ISSN
2375-2548 (ISSN-L)
OpenAlex
W2946741946
Cited by
101
References
27
Citations by year
2026: 4 · 2025: 9 · 2024: 17 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 13 · 2019: 9
FWCI
4.38
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
National Research Foundation of Korea (2018R1A2A1A05079172, 2016M3A9B6948494, 2018M3A9H3024850, 2018R1A2B2001322)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Keywords
single-cell RNA sequencing, transient transfection, Drop-seq, gene expression signatures, species mixing, transcriptomic response
MeSH terms
RNA-Seq, Algorithms, Animals, Humans, Oligonucleotides, RNA, Stochastic Processes, Cluster Analysis, K562 Cells, Gene Expression Profiling, NIH 3T3 Cells, Cell Line, Tumor, Mice, HEK293 Cells, Single-Cell Analysis, High-Throughput Nucleotide Sequencing, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations. https://app.cochat.ai/papers/10.1126/sciadv.aav2249
The paper
Shin, D., Lee, W., Lee, J. H., & Bang, D. (2019). Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations. Science Advances. https://doi.org/10.1126/sciadv.aav2249

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.